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1 PURPOSE OF THE DAP BONE REMODELING MODEL 
Under the conditions of microgravity, astronauts lose bone mass at a rate of 1% to 2% a month, particularly in the 
lower extremities such as the proximal femur [1–3]. The most commonly used countermeasure against bone loss in 
microgravity has been prescribed exercise [4]. However, data has shown that existing exercise countermeasures are 
not as effective as desired for preventing bone loss in long duration, 4 to 6 months, spaceflight [1,3,5,6]. This 
spaceflight related bone loss may cause early onset of osteoporosis to place the astronauts at greater risk of fracture 
later in their lives. Consequently, NASA seeks to have improved understanding of the mechanisms of bone 
demineralization in microgravity in order to appropriately quantify this risk, and to establish appropriate 
countermeasures [7]. 
In this light, NASA’s Digital Astronaut Project (DAP) is working with the NASA Bone Discipline Lead to 
implement well-validated computational models to help predict and assess bone loss during spaceflight, and enhance 
exercise countermeasure development.  More specifically, computational modeling is proposed as a way to augment 
bone research and exercise countermeasure development to target weight-bearing skeletal sites that are most 
susceptible to bone loss in microgravity, and thus at higher risk for fracture. Given that hip fractures can be 
debilitating, the initial model development focused on the femoral neck. Future efforts will focus on including other 
key load bearing bone sites such as the greater trochanter, lower lumbar, proximal femur and calcaneus. 
The DAP has currently established an initial model (Beta Version) of bone loss due to skeletal unloading in femoral 
neck region.  The model calculates changes in mineralized volume fraction of bone in this segment and relates it to 
changes in bone mineral density (vBMD) measured by Quantitative Computed Tomography (QCT).  The model is 
governed by equations describing changes in bone volume fraction (BVF), and rates of changes in bone cell 
populations that remove and replace bone in packets within the bone region.  
The DAP bone model is unique in several respects. In particular in takes former models of volume fraction changes 
one step higher in fidelity and separates BVF into separate equations for mineralized and osteoid volume fractions 
governed by a mineralization rate. This more closely follows the physiology of the remodeling unit cycles where 
bone is first resorbed and then followed by the action of osteoblasts to lay down collagen matrix which eventually 
becomes mineralized. In another respect, the modules allow the functional description of the time rate of change of 
other parameters and variables in the model during a computational simulation. More detailed description of the 
model, preliminary validation results, current limitation and caveats, and planned advancements are provided in 
sections 2 through 5. 
The DAP bone model is being developed primarily as a research tool, and not as a clinical tool like QCT. Even if it 
transitions to a clinical tool, it is not intended to replace QCT or any other clinical tool. Moreover, the DAP bone 
model does not predict bone fracture. Its purpose is to provide valuable additional data via “forward prediction” 
simulations for during and after spaceflight missions to gain insight on, (1) mechanisms of bone demineralization in 
microgravity, and (2) the volumetric changes at the various bone sites in response to in-flight and post-flight 
exercise countermeasures. This data can then be used as input to the Keyak [8] (or equivalent) FE analysis method 
to gain insight on how bone strength may change during and after flight. This information can also be useful to help 
optimize exercise countermeasure protocols to minimize changes in bone strength during flight, and improve regain 
of bone strength post-flight. To achieve this goal, the bone model will be integrated with DAP’s exercise 
countermeasure models to simulate the effect of exercise prescriptions on preserving bone. More specifically, the 
model will accept loading history due to muscle and joint force on bone and produce quantified remodeling within 
the bone region under influence of the applied stress. Furthermore, because they tend to respond differently, the 
bone remodeling model includes both trabecular bone and cortical bone. Figure 1 illustrates this application process. 
The bone remodeling model will be particularly be useful for providing data for time periods where QCT is not 
available. Currently, because only few QCT scans can be acquired from each crewmember, FE strength analyses can 
only be done at specific snapshots in time. Furthermore, there is currently no way to track or predict bone changes 
during flight to accurately track changes in cortical and trabecular bone. Therefore, the model can be used to 
estimate the time course change of vBMD during an exploration mission and between the scans astronauts undergo 
after they return to Earth.  This data can then be used for FE strength analysis method to gain insight on how bone 
strength may change over time and to refine exercise countermeasure protocols to minimize changes in bone 
strength during flight, and improve regain of bone strength post-flight (Figure 1). 
3 
 
Figure 1: Illustration of how the DAP bone remodeling model will be used to perform “forward prediction” simulations to 
gain insight on the volumetric changes in bone and how bone strength is affected based on FE method. 
2 OVERVIEW OF THE DAP MODEL 
The Digital Astronaut Project (DAP) bone remodeling computational model (Beta Version) consists of a 1st order 
nonlinear system of differential equations that govern the time rate of change in bone via the bone remodeling 
process. To account for change, the model tracks BVF of a representative volume element of a specific skeletal site 
or bone segment, which is divided into the mineralized volume fraction plus the osteoid volume fraction. The time 
rate of change of the volume fractions are functions of the areas removed and replaced in a cross section of a 
representative volume element by the cells in the remodeling units, activation frequency, and normalized active cell 
populations.  
The differences between trabecular bone and cortical bone are captured in part by the differences in the geometry 
and the process of removal/replacement in the remodeling units. In trabecular, the structural unit is a packet shaped 
like a crescent (hemi-osteon) on the surface of a rod or plate like element. In cortical bone the structural unit is a 
single Haversian system (Osteon) shaped like a cylinder and referred to as a cutting cone [9]. Differences in other 
parameters, like activation density also distinguish trabecular bone from cortical bone.  Thus, there are two separate 
computational modules: one for trabecular bone and one for cortical bone. 
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The normalized active cell populations are themselves governed by equations in the system that model the 
physiology of resorption and formation via the dynamics of the active bone resorbing cells, osteoclasts, the active 
bone forming cells, osteoblasts, and the responding osteoblasts. Considered a composite of several phenotypes (i.e., 
early osteoblasts or preosteoblasts), the term responding osteoblasts is not considered a true cell type [10]. Rather, it 
is a category that uncommitted progenitors commit to differentiating into. Osteoblasts progenitors are modeled 
implicitly as a reservoir source as well as the osteoclasts progenitors. . 
Bone remodeling literature encompasses a vast amount of research on the endocrine, biochemical, autocrine, and 
paracrine interactions involving receptors and ligands. With regard to bone-cell communication and the role played 
by receptor-ligand pathways, a large number of hypotheses have been postulated. Although there is much that is not 
understood about the process, the DAP bone remodeling model mathematically formulates the key elements based 
on well accepted knowledge and experimental studies of bone. In particular, the RANK-RANKL-OPG signaling 
pathway discovered in the mid-90s is the essential part of the cellular dynamics. It’s the balanced signaling pathway 
that’s followed through the sequence of each complete remodeling unit cycle. Causes of bone loss or effects of 
therapeutic drugs can often be traced to disturbances in this pathway, and it is fundamental principle under which the 
model is implemented computationally. 
Another key element is the mathematical formulation of the effects of nitric oxide and prostaglandin E2 which takes 
into account the contribution to the bone remodeling and bone density balance from skeletal loading. Osteocytes 
(and possibly bone lining cells), which are assumed to be the mechanosensors, have been shown experimentally to 
release the cellular signaling molecule NO and the paracrine PGE2 in response to mechanical loading. Although they 
can have an inhibiting effect as well as a stimulating effect, both have been found to contribute to bone formation 
either by direct mediation in the RANK-RANKL-OPG pathway or by indirect promotion of cell differentiation. In 
the computation model, reduced skeletal loading triggers a decrease in NO and PGE2, which in turn triggers an 
imbalance in the pathway in favor of resorption. This leads to a decrease in mineralized volume M and osteoid 
volume O, and hence a decrease in BVF. Although the skeletal loading contribution to the maintenance of bone 
health has been modeled in, it is important to realize that mechanotransduction theory requires phases from 
mechanocoupling to the final effector response. Mechanical signals can directly affect bone cells or be turned into 
chemical signals. The effector cells, i.e., osteoblasts and osteoclasts, respond to the original stimulus via a 
complicated cascade of events, the details of which are not yet fully established. Frost’s mechanostat theory that 
relates loading-induced strain magnitudes to bone gain or bone loss, defines a lower threshold or minimum effective 
strain. The model incorporates the more comprehensive concept of a minimum effective strain stimulus which can 
take into consideration strain rate as opposed to strain magnitude only. The mathematical formulation develops the 
concept of a mechanical stimulus “strength” that quantifies the average daily strain accumulated from dynamic 
loading. Other than a zero load for complete disuse, this aspect of the model needs testing and further development 
with regard to specific exercise-induced loading. Therefore, the current beta version of the DAP bone remodeling 
model considers only the bone deconditioning due to mechanical unloading. 
In short, the model consists of three major research areas, (1) the orthopedic science or mechanics of the removal 
and replacement of bone packets via remodeling units, (2) the biology and physiology of cellular dynamics of 
remodeling units, and (3) mechanotransduction which describes the function of skeletal loading and its role in 
maintaining bone health. The basic biological assumption used in the cellular physiology can be stated as such: Cell 
proliferation (anti-proliferation) is directly proportional (inversely proportional) to receptor occupancy ratio [11].  
Values associated with parameters referred to in the discussion thus far are still under active research by scientists.  
Due to the uncertainty and variability, our approach was to use average values based on experimental studies in the 
literature or assumed values based on experimental studies on ribs or the iliac crest.  A selected example of these is 
as follows: 
 Resorption depth (depth of remodeling unit): An average value of 0.5 mm for trabecular hemi-osteon is 
used based on values reported in [12–15]. For cortical bone, femoral neck values for osteonal diameter and 
Haversian canal diameter were used that were reported for controls in studies of hip fractures and 
osteoarthritis  in [16,17]. 
 Activation frequency: For cortical bone an average of the value reported for three age groups covering ages 
30 to 59 from a histological study of ribs by Frost (1969) can be used [18].  In the case of trabecular 
average values reported vary greatly. A sample includes 0.45/yr reported by Dempster et al. (1999) [19], 
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0.53/yr reported by Chapurlat et al. (2007) [20], 0.42/yr reported by (Mayo Clinic ppt).  Since our model 
uses a value in terms of #/day any value of about 0.36/yr to 0.53/yr gives a value rounded to three digits of 
0.001/day. 
 TGF-beta 1: Because the amount of TGF-beta 1 involved in the remodeling process comes from the 
amount released during bone resorption we needed a value of the amount contained in bone. A value of 200 
μg/kg is reported by Janssens et al. (2005) and Bonewald and Mundy (1990) [21,22]. 
 Receptor occupancy ratios: For a given ligand receptor pair, the ratio has a dissociation constant reference 
value.  For TGF-beta 1 a value for trabecular receptors reported by Tripathi et al. (1993) is used [23]. 
Given that remodeling is the normal physiological mechanism for bone replacement or repair in the adult skeleton, 
the computational model is best suited for the mature adult between 25 and 55 years of age, or typical age of an 
astronaut. The primary application of the DAP bone remodeling model is to track bone loss in astronauts during 
spaceflight and bone recovery post flight. Skeletal sites at high risk include the proximal femur (femoral neck), 
lower lumbar spine, and calcaneus. Our current efforts in developing the model are aimed at the femoral neck since 
the femoral neck has been identified as the site with the highest risk for fracture. 
The shape of the femoral neck conforms approximately to a “short” cylindrical cylinder and acts like a cantilever 
during locomotion [24]. Trabeculae that accommodate tensile stresses and trabeculae that accommodate 
compressive stresses intersect at right angles in a significant part of the neck [25]. We assume that due to the 
approximate regular geometry of the femoral neck, the BVF of volume elements throughout the neck will not vary 
widely. Therefore the vBMD and BVF of the representative volume element of the computational model and its 
adaptive changes can be expected to represent an estimate of the average value of the femoral neck’s volume 
elements. 
Currently, the model implementation is coded with a specific scheme to match vBMD values from QCT scanning 
technology presently use by NASA for flight and bed rest studies, and under consideration for use as part of the new 
bone strength standard measure. Correlation equations relating vBMD to ash density developed by Keyak [8] are 
used in the first step of the scheme to eventually relate ash density to mineralized volume fraction. 
We are validating the model’s capability to represent deconditioning of the femoral neck due to unloading using data 
from control subjects participating in the current 70-day bed rest study (CFT70), a 17-week bed rest study reported 
in [26,27], as well as literature data for BVF simulations. More specifically, we use pre-bed rest and post-bed rest 
QCT and DXA density scans obtained from control subjects to validate the model’s ability to track trabecular and 
cortical vBMD, and integral BMDa changes. We also compare the simulated BVF with experimental values 
reported in literature. Section 3 discusses the preliminary validation results for the beta version of the bone model. 
3 PRELIMINARY VALIDATION RESULTS 
The NASA Human Research Program requires that all models and simulations (M&S) that can potentially impact 
the crew health or mission must be verified and validated in accordance to NASA’s Standard for Models and 
Simulations (NASA-STD-7009). In this light, we are working to verify and validate the DAP bone remodeling 
model to ensure that it can be used reliably used for the intended application as described in section 1. This section 
will summarize the preliminary model validation results for bone deconditioning due to gravitational unloading 
under bed rest conditions. 
It is important to note that the term “validation” does not mean the absolute substantiation of the model’s capability 
to capture the bone remodeling process. Validation refers to the degree which the model is able to reproduce the 
observed behavior of a specific parameter or variable under consideration (e.g. BMD or BVF) in comparison to 
experimental data, real world observations or expert opinion. For example, if the model is compared against vBMD 
readings from bed rest control subjects, the validation activity is only indicative of the model’s capability to 
reproduce vBMD changes under bed rest conditions without countermeasure. It would not validate the behavior of 
any other parameters or variables. At best, it would only have indirect implications to other parameters or variables 
based on subject matter expert input and with appropriate justifications. 
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2. Validation analysis of the computational predictions for deconditioning has only been done for up to 4 months 
in duration.  
3. The validation data used is from bed rest control subjects as an analog to gravitational unloading due to 
exposure to microgravity. Although bed rest is viewed as a good analog for microgravity, any differences that 
may exist between bed rest and microgravity with regards to the mechanisms of bone loss are not fully 
understood. Nevertheless, this is not a problem that is unique to the model, but rather due to the limited state of 
knowledge in bone science. 
4. Age and gender differences are not yet factored in when initializing model variables and mapping the BMD or 
other initial types of data to the model’s state variables.  
5. The model does not include the effects of sclerotin, calcitonin, osteopotin, or Interleukins, some of which may 
play a role in the difference between bone loss in microgravity and disuse bone loss in 1 g.  
Some key caveats that should be taken into consideration are included below. These are due to the inherent 
limitations imposed by the state of knowledge in bone science. 
1. There is a degree of uncertainty and variation in remodeling unit geometry and dimensions reported in the 
literature. It is also difficult to guarantee that the values used in the model agree for the particular skeletal site of 
interest. Changes can change the results.  
2. There is uncertainty in the way ash fraction is modeled, and the full potential range of values estimated from 
experimental studies is not completely understood. 
3. Activation frequency and activation density are inherently difficult to appropriately model due to the lack of 
human values at skeletal sites other than the iliac crest or rib. 
4. There are several potential algebraic schemes for mapping initial data values to model state variables. They 
depend on several possible definitions of ash fraction and how the steady state version of their respective 
equations are used. Further testing with additional data is needed. 
5 FUTURE WORK 
There are several areas of work that we need to complete before the model can be sufficiently mature to inform the 
bone research relating to bone strength standard development effort and exercise physiology. The areas of future 
development include:  
1. Testing, evaluating, and resolving uncertainty in the model parameter values such as ash fraction, activation 
density, activation frequency.  
2. Developing of appropriate methods for mapping experimental data to model variables must be developed. 
3. Integrating with or leveraging data generated by biomechanics exercise models to predict the benefit exercise 
countermeasures for mitigating bone loss. 
4. Extending the predictive capability of the model to simulate bone adaptation due to gravitational unloading and 
response to exercise countermeasures for up to one year. 
5. Adapting the model to other skeletal sites such as the trochanter, total femur and lumbar spine. 
6. Performing rigorous verification, sensitivity and uncertainty analysis of the system of equations, as well as key 
parameters and variables that describe the bone adaptation process. 
7. Tracking integral vBMD changes by accounting for the endosteal region in additional to the trabecular and 
cortical regions. 
8. Adding age and gender related dependencies.  
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